Investigations on biomarker search in patients with non-small-cell bronchial carcinoma under checkpoint inhibitor therapy
- Conditions
- C34.9Bronchus or lung, unspecified
- Registration Number
- DRKS00022767
- Lead Sponsor
- Krankenhaus Martha-Maria Halle-Dölau
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 92
Inclusion Criteria
Patients must be able to give consent themselves
- signed consent form
- histologically confirmed NSCLC with indication for palliative immunotherapy with or without chemotherapy
Exclusion Criteria
- histologically confirmed SCLC
- previous immunotherapies
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method progressionfree survival<br>- controll via CT and MRI after 4th cycle of immunotherapy and afterwards every 3 month or if there is clinical indication of progress
- Secondary Outcome Measures
Name Time Method Overall survival<br>- controll every 3 month<br>- acquiation via Klinisches Krebsregister or genaral practitioner